Modelling light propagation for fetal monitoring in utero

Research output: Chapter in Book/Report/Conference proceedingsChapterpeer-review

Abstract

About one in three births in the United States is through Cesarean section. Current monitoring techniques are insufficient to determine hypoxia and acidosis in the fetus during labor. An FDA approved transvaginal fetal pulse oximeter has been used in clinical trials to show that the device can help decrease the rate of Cesarean section. However, this technique has not been adapted into normal hospital procedure. Past pre-clinical and clinical studies have shown the feasibility of transabdominal fetal pulse oximetry. To understand the fundamentals of transabominal fetal pulse oximetry, we examined a layer model with both Monte Carlo and NIRFAST simulations. The NIRFAST model was used to model concentric spheres to understand the effect on geometry. The simulations were used in order to determine how much optical power can be detected from the fetus with a light source at 850 nm. The signal decreased as the fetal depth increased and as source-detector distance increased. The results can be used to aid in the design of a transabdominal fetal pulse oximeter.

Original languageEnglish
Title of host publicationEuropean Conference on Biomedical Optics, ECBO_2019
EditorsHamid Dehghani, Heidrun Wabnitz
PublisherOptica Publishing Group (formerly OSA)
ISBN (Electronic)9781510628410
ISBN (Print)9781510628397
DOIs
Publication statusPublished - 2019
EventEuropean Conference on Biomedical Optics, ECBO_2019 - Munich, Netherlands
Duration: 23 Jun 201925 Jun 2019

Publication series

NameOptics InfoBase Conference Papers
VolumePart F142-ECBO 2019
ISSN (Electronic)2162-2701

Conference

ConferenceEuropean Conference on Biomedical Optics, ECBO_2019
Country/TerritoryNetherlands
CityMunich
Period23/06/1925/06/19

Keywords

  • Fetal monitoring
  • Light propagating
  • Monte Carlo
  • NIRFAST
  • Pulse oximetry

Fingerprint

Dive into the research topics of 'Modelling light propagation for fetal monitoring in utero'. Together they form a unique fingerprint.

Cite this